Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 37,906 | 33,040 | 33,137 | 35,319 | 33,584 |
| Operating Income | -37,906 | -33,040 | -33,137 | -35,319 | -33,584 |
| Interest Expense | 2,759 | 2,775 | 1,485 | 1,256 | 1,272 |
| Other Income | 0 | -11 | -2,040 | 23 | 13 |
| Pre-tax Income | -40,665 | -35,826 | -36,662 | -36,552 | -34,843 |
| Net Income Continuous | -40,665 | -35,826 | -36,662 | -36,552 | -34,843 |
| Net Income | $-40,665 | $-35,826 | $-36,662 | $-36,552 | $-34,843 |
| EPS Basic Total Ops | -1.07 | -0.95 | -0.98 | -1.00 | -0.96 |
| EPS Basic Continuous Ops | -1.07 | -0.95 | -0.98 | -1.00 | -0.96 |
| EPS Diluted Total Ops | -1.07 | -0.95 | -0.98 | -1.00 | -0.96 |
| EPS Diluted Continuous Ops | -1.07 | -0.95 | -0.98 | -1.00 | -0.96 |
| EBITDA(a) | $-37,260 | $-32,398 | $-30,617 | $-34,854 | $-33,095 |